Related Experiment Videos
A clinical staging classification for type C Niemann-Pick disease
J J Higgins1, M C Patterson, J M Dambrosia
1Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Neurology
|December 1, 1992
Summary
Niemann-Pick type C disease progression varies by onset age. Preschool onset shows higher mortality and distinct neurologic stages compared to school-age onset Niemann-Pick C patients.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Niemann-Pick type C (NPC) is a rare genetic lysosomal storage disorder.
- It leads to progressive neurodegeneration and organ damage.
- Understanding disease progression is crucial for patient management.
Purpose of the Study:
- To analyze the temporal sequence of neurologic events, neurophysiologic abnormalities, and longevity in Niemann-Pick type C patients.
- To identify distinct clinical subgroups and stages of disease severity.
- To compare outcomes between different onset groups.
Main Methods:
- Analysis of neurologic events, neurophysiologic data, and survival in 36 Niemann-Pick type C patients.
- Classification into two clinical subgroups based on onset age (preschool vs. school-age).
- Definition of five severity stages (0-4) within each subgroup.
Main Results:
- Two distinct clinical subgroups were identified: preschool onset (Group I) and school-age onset (Group II).
- Preschool onset (Group I) exhibited higher mortality than school-age onset (Group II).
- Specific neurologic and neurophysiologic milestones defined five progressive stages (0-4) for each group, including movement disorders, cognitive decline, gaze palsy, and pyramidal signs.
Conclusions:
- Niemann-Pick type C disease presents with distinct clinical trajectories based on age of onset.
- A detailed staging system aids in understanding disease progression and predicting outcomes.
- Early onset is associated with a poorer prognosis in Niemann-Pick type C.